To investigate whether PRDM16-DT is dysregulated in neurodegenerative diseases, we analyzed its expression in postmortem brain samples (prefrontal cortex, BA9) obtained from healthy controls and patients with AD. The gene discussed is PRDM16; the disease is neurodegenerative disease.